Back to Search
GEORGE SLEDGE, M.D.
M.D.
Medical Oncology Physician
NPI: 1780640318IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
C55993(CA)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
01032928(IN)C55993(CA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
C55993(CA)
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 1983
Research & Publications (20)
The rapid evolution of breast cancer therapeutic agents.
PMID 19158034·Clin Breast Cancer·2008
8-other
The new millennium for adjuvant therapy in breast cancer.
PMID 18561550·Oncology (Williston Park)·2008
6-review
The role of angiogenesis inhibition in the treatment of breast cancer.
PMID 17139244·Clin Adv Hematol Oncol·2006
6-review
Protein kinase C-beta as a therapeutic target in breast cancer.
PMID 16797377·Semin Oncol·2006
6-review
New developments in adjuvant therapy for breast cancer.
PMID 16224442·Clin Adv Hematol Oncol·2005
7-preclinical
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
PMID 12586793·J Clin Oncol·2003
3-trial
Is HER-2/neu a predictor of anthracycline utility? No.
PMID 11773298·J Natl Cancer Inst Monogr·2001
8-other
Comparison of chemotherapy with chemohormonal therapy as first-line therapy for metastatic, hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group study.
PMID 10637238·J Clin Oncol·2000
3-trial
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.
PMID 19620488·J Clin Oncol·2009
8-other
Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?
PMID 19519950·Breast Cancer Res·2009
7-preclinical
Cognitive function in breast cancer survivors compared to healthy age- and education-matched women.
PMID 19156566·Clin Neuropsychol·2009
4-observational
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen.
PMID 19214387·Invest New Drugs·2009
3-trial
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes.
PMID 18785001·Breast Cancer Res Treat·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 269 Campus Dr, Administrative office: CCSR 1115
Stanford, CA 94305 - Phone
- (999) 999-9999
Quick Facts
- NPI
- 1780640318
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile